Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Posch, N; Semlitsch, T; Wratschko, K; Siebenhofer, A.
[Factors promoting and hindering the use of an evidence-based clinical pathway for the management of overweight or obese children and adolescents].
Z Evid Fortbild Qual Gesundhwes. 2021; 165: 21-26.
Doi: 10.1016/j.zefq.2021.06.003
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Posch Nicole
- Semlitsch Thomas
- Co-Autor*innen der Med Uni Graz
- Siebenhofer-Kroitzsch Andrea
- Wratschko Kerstin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND/OBJECTIVE: Evidence-based clinical pathways can be a useful tool for guideline implementation. However, there seem to be barriers to the use of clinical pathways. The aim of the present questionnaire survey was to assess the perceived usability of the clinical pathway "Overweight/obesity in children and adolescents at primary care level" and to identify factors promoting and hindering the use of the clinical pathway. METHODS: In January 2020, an online questionnaire survey was sent out to 3,916 general practitioners and 470 pediatricians in Austria. The data collected were analysed descriptively. RESULTS: A total of 148 people took part in the questionnaire survey (response rate 3.7 %). The majority of respondents indicated that they, in general, perceive evidence-based clinical pathways as helpful (90 %) and also make use of them (57 %). Few respondents (9 %) felt well-informed about new clinical pathways developed in Austria. Most of the respondents considered the clinical pathway "Overweight/obesity in children and adolescents at primary care level" as a useful support (60 %), as a reference work (72 %) or as a facilitator for justifying their approach to their patients (68 %). However, a large proportion of the respondents stated that the clinical pathway is not easily applicable in everyday practice. The three most frequently cited barriers to using the clinical pathway were lack of time resources, lack of structures and lack of financial incentives. Other display and access options (e. g., individualisation, integration into practice software) were most frequently cited as factors that might promote the use of the pathway. CONCLUSION: Although the majority of the respondents had positive expectations regarding the use of the clinical pathway "Overweight/obesity in children and adolescents at primary care level", many of them still perceived its usability in everyday clinical practice as difficult. The necessary next steps to improve the use of evidence-based clinical pathways seem to be: an economic and practicable design, easy accessibility of clinical pathways and the creation of framework conditions that facilitate their use in everyday practice.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent - administration & dosage
- Child - administration & dosage
- Critical Pathways - administration & dosage
- Germany - administration & dosage
- Humans - administration & dosage
- Motivation - administration & dosage
- Overweight - therapy
- Pediatric Obesity - therapy
- Find related publications in this database (Keywords)
- Clinical pathway
- Evidence-based
- Primary health care
- Usability
- Overweight